Nanotechnologies: evidence-based regulation
Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02260 | Published on: 20/02/2024
DOI:
https://doi.org/10.22239/2317-269x.02260Keywords:
Nanoparticles, Nanomaterial, Nanosafety, Regulatory ScienceAbstract
The debate on best practices for the regulation of nanotechnologies needs to be deepened and still represents a challenge for Brazilian society, political authorities, and regulatory bodies. In recent years, there has been much discussion about the regulation of nanotechnologies; however, as a disruptive technology due to its complexity, limitations in the validation of analysis methodologies, and the scarcity of references on nanoparticles and nanomaterials, significant asymmetries and difficulties in understanding of best regulatory practices persist. Due to the limited technical and scientifically validated evidence, regulatory models known as “command and control” and the precautionary principle are used to prevent concrete/abstract but plausible dangers. As an alternative to the current regulatory model, this paper discusses the regulatory model considered the best global regulatory practice, which relies on regulatory science and evidence-based regulation. There is growing global acceptance of using technically and scientifically validated evidence to assist political and regulatory authorities in developing guidelines and regulatory standards that can protect public interests and maximize new technologies’ economic and social benefits. Furthermore, evidence allows for anticipating potential risks and enables proactive approaches to the regulation of nanotechnologies. When considering this perspective, it is essential to emphasize that implementing an evidence-based regulatory model requires political, scientific, technical, and regulatory maturity to ensure that the benefits are harnessed to provide prosperity, safety, and sustainability through the use of disruptive technologies.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pedro Canisio Binsfeld, José Mauro Granjeiro (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.